{"schema_version":"secwatch.filing_event.v1","accession":"0000929638-24-000283","form_type":"8-K","ticker":"ICU","cik":"0001831868","company_name":"SeaStar Medical Holding Corp","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.822100+00:00","generated_at":"2026-06-06T15:10:02.779709+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"SeaStar Medical raises $9.0M in registered direct offering and private placement of shares and warrants","bullets":["Gross proceeds of approx. $9.0M from sale of common stock, pre-funded warrants, Series A and B warrants at combined price of $0.8302/unit.","Offering includes 10,840,761 common shares (or pre-funded warrants) plus warrants for up to 16,261,142 additional shares.","Maxim Group LLC acted as sole placement agent; offering expected to close on or about January 30, 2024.","Institutional investor agreed to waive certain optional redemption rights on existing convertible notes for 60 days."],"urls":{"canonical":"https://secwatch.observer/filing/0000929638-24-000283","json":"https://secwatch.observer/filing/0000929638-24-000283.json","markdown":"https://secwatch.observer/filing/0000929638-24-000283.md","text":"https://secwatch.observer/filing/0000929638-24-000283.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831868/000092963824000283/0000929638-24-000283-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831868/000092963824000283/a8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:10:02.779709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13105275424ca3f16c1e14386d9579c78a601cff","claim":"SeaStar Medical Holding Corp entered into Securities Purchase Agreement with a single institutional investor valued at approximately $9.0 million (effective 2024-01-26).","evidence_excerpt":"On January 26, 2024, SeaStar Medical Holdings Corporation (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single institutional investor (the “Purchaser”), pursuant to which the Company will issue to the Purchaser, (i) in a registered direct offering, 6,304,545 shares of the Company’s common stock (the “Shares”), par value $0.0001 per share (“Common Stock”), and pre-funded warrants to purchase 4,536,216 shares of Common Stock (the “Pre-Funded Warrants”) with an exercise price of $0.0001 per share, and (ii) in a concurrent private placement, series A warrants to purchase 10,840,761 shares of Common Stock (the “Series A Common Warrants”) and series B warrants to purchase 5,420,381 shares of Common Stock (the “Series B Common Warrants” and together with the Series A Common Warrants, the “Common Warrants”) each with an exercise price of $0.8302.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000092963824000283/0000929638-24-000283-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a single institutional investor"},{"label":"Value","value":"approximately $9.0 million"},{"label":"Effective","value":"2024-01-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}